Date created

Management changes at Celesio

Brian Tyler, current President and Chief Operating Officer (COO) of Celesio, to become Chairman of the Celesio Management Board, effective 1 April 2017.

Marc Owen, current Chairman of the Celesio Management Board, to retire after 15 years with McKesson, including nearly three years leading Celesio, effective 31 March 2017.

The Supervisory Board of Celesio AG (“Celesio”) has appointed Brian Tyler Chairman of the Management Board, effective 1 April, 2017. Tyler will succeed Marc Owen, current Chairman of the Management Board of Celesio, who has decided to retire after 15 years with McKesson, including nearly three years leading Celesio.

Download Press release (PDF 163 KB)

“I am pleased to announce Brian Tyler’s appointment as Chairman of the Management Board,” said John H. Hammergren, Chairman of the Supervisory Board of Celesio. “During the past nine months as President and COO of Celesio, Brian has helped further improve the business’ operational excellence and facilitate collaboration across our European businesses to benefit our customers and business partners. Brian is ideally suited to help Celesio ensure a seamless transition and achieve the next chapter of growth.”

A 20-year McKesson veteran, Brian Tyler has served as President of North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical, and McKesson Specialty Health, as well as Executive Vice President of Corporate Strategy and Business Development.

“I would like to thank Marc for his leadership at the helm of Celesio for nearly three years,” added Hammergren. “Few individuals have had a greater impact on McKesson’s success over the past 15 years than Marc Owen. During the ten years he ran McKesson’s Corporate Strategy and Business Development team, he served as the architect for some of the most important strategic decisions we have made as a company, including the acquisition of US Oncology, the creation of the NorthStar generics business, and the expansion into Europe.”

Before joining Celesio, he served as President of McKesson Specialty Health, a division of McKesson Corporation that distributes oncology and other specialty drugs to physicians and other healthcare providers throughout the United States. Under Marc Owen’s leadership, McKesson Specialty Health achieved a leading market share position in community oncology. Marc Owen was appointed Chairman of the Celesio Management Board in July 2014. 

Portrait pictures for download:

About the Celesio Group

Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sector. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care.

With strong brands and about 36,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; Celesio manages operations in two countries and participates in one country in a joint venture). Every day, the company serves over 2 million customers – at more than 2,150 pharmacies of its own, at about 300 managed pharmacies and at over 5,500 participants in the brand partnership schemes. With 109 wholesale branches in Europe, Celesio supplies more than 50,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.

McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.

Press contact

Marc Binder, Director Group Communications
Marc Binder
Senior Vice President Group Communications
+49 711 5001-380
Rainer Berghausen, Head of Group External Communications
Rainer Berghausen
Head of Group External Communications
+49 711 5001-549